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ABSTRACT
In human and mouse, the promoter of the KRAS gene
contains a nuclease hypersensitive polypurine–
polypyrimidine element (NHPPE) that is essential
for transcription. An interesting feature of the poly-
purine G-rich strand of NHPPE is its ability to
assume an unusual DNA structure that, according
to circular dichroism (CD) and DMS footprinting
experiments, is attributed to an intramolecular
parallel G-quadruplex, consisting of three G-tetrads
and three loops. The human and mouse KRAS
NHPPE G-rich strands display melting tempera-
ture of 64 and 73 C, respectively, as well as a
K
1-dependent capacity to arrest DNA polymerase.
Photocleavage and CD experiments showed that
the cationic porphyrin TMPyP4 stacks to the external
G-tetrads of the KRAS quadruplexes, increasing
the Tm by  20 C. These findings raise the intriguing
question that the G-quadruplex formed within the
NHPPE of KRAS may be involved in the regulation
of transcription. Indeed, transfection experiments
showed that the activity of the mouse KRAS pro-
moter is reduced to 20% of control, in the presence
of the quadruplex-stabilizing TMPyP4. In addition,
we found that G-rich oligonucleotides mimicking
the KRAS quadruplex, but not the corresponding
4-base mutant sequences or oligonucleotides form-
ingquadruplexeswithdifferent structures,competed
with the NHPPE duplex for binding to nuclear pro-
teins. When vector pKRS-413, containing CAT driven
by the mouse KRAS promoter, and KRAS quad-
ruplex oligonucleotides were co-transfected in 293
cells, the expression of CAT was found to be down-
regulated to 40% of the control. On the basis of
these data, we propose that the NHPPE of KRAS
exists in equilibrium between a double-stranded
form favouring transcription and a folded quadruplex
form, which instead inhibits transcription. Such a
mechanism, which is probably adopted by other
growth-related genes, provides useful hints for
the rational design of anticancer drugs against the
KRAS oncogene.
INTRODUCTION
Pancreatic ductal adenocarcinoma is an aggressive disease,
which is characterized by a rapid progression and little
response to conventional cancer treatments (1). Like many
other tumours, pancreatic cancer results from the accumula-
tion of genetic lesions in various genes: proto-oncogenes,
tumour-suppression and maintenance genes (2,3). The
KRAS gene is located in chromosome 12, locus 12p12.1,
and encodes for a 21 kDa protein, p21
RAS, which is anchored
to the inner surface of the plasma membrane and acts as a
molecular switch that transmits to the nucleus, through the
Raf-MAP kinase pathway, signals that inﬂuence cell growth
and apoptosis (4). Protein p21
RAS exists in two states, a
GTP-bound active state and a GDP-bound inactive state.
The activity of p21
RAS is regulated positively by nucleotide
exchange factors and negatively by a GTPase activating pro-
tein. When there is a point mutation in codon 12 (5), the
protein islocked in the active state and constitutively transmits
to the nucleus mitogenic signals. In a recent work, Hingorani
et al. (6) have investigated the role of oncogenic RAS muta-
tions in the pancreatic tumorigenesis. They demonstrated that
the endogenous expression of an oncogenic KRAS allele
(KRAS
G12D) in mouse pancreas initiates the development of
pancreatic ductal adenocarcinoma in a way identical to that
occurring in the cognate human condition. The rapid accumu-
lation of knowledge on the molecular biology of pancreatic
adenocarcinoma has stimulated the development of targeted
therapies for this disease. Strategies aiming at the suppression
of KRAS expression (7–11) or inactivation of the Ras protein
(12) have been proposed. In this context, we have addressed
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doi:10.1093/nar/gkl286our efforts on a polypurine–polypyrimidine motif located in
the KRAS promoter, between nt  327 and  296 in human;
 318 and  290 in mouse (13,14). Polypurine–polypyrimidine
motifs are simple repeats distributed through the eukaryotic
genomes (15) and often are present in the 50 region of the
genes. The CMYC region between  142 and  115 from the
P1 promoter which controls 80–90% of transcription (16),
harbours a polypurine–polypyrimidine motif that extrudes a
G-quadruplex structure involved in transcription regulation
(17,18). In Drosophila, the 50 region of HSP26 and HSP70
contains a polypurine–polypyrimidine stretch that binds to
nuclear proteins and activates transcription (19). In the prox-
imal promoter region of the human VEGF gene there is a poly-
purine-polypyrimidine sequence forming a G-quadruplex (20).
In addition, other genes contain oligopurine tracts in the regu-
latory regions (e.g. c-fes/fps, c-ets-2, c-myb, c-src) (21–24).
Studies on chromatin showed that the KRAS polypurine–
polypyrimidine motif is a nuclease hypersensitive element
(NHPPE), suggesting that it may adopt a non-B-DNA struc-
ture (13,14). NHPPE is essential for the promoter activity
as its excision results in a signiﬁcant downregulation of tran-
scription (14). Owing to its critical role, we have previously
targeted NHPPE with triplex-forming oligonucleotides
(TFOs) (9). In the ﬁrst approach we successfully targeted a
reporter gene driven by the KRAS promoter. However, when
the designed TFOs were used against endogenous KRAS,w e
did not obtain satisfactory results. We though that the TFO
uptake might be a serious obstacle, thus we obtained from
Panc-1 cells a stable transfectant line in which an anti-KRAS
TFO was endogenously produced (10). In the transfectant
line, we observed that oncogenic KRAS was downregulated
and as a result cell proliferation and colony formation were
strongly reduced, while apoptosis was enhanced. However,
we believed that these cellular effects could not be ascribed
to the formation of a triplex between the endogenous TFO
and NHPPE, as in vitro experiments suggested that the
RNA DNA DNA triplex was not stable enough to elicit
such strong cellular effects. Interestingly, we found that the
anti KRAS activity of the endogenous TFO correlated with
its ability assume a G-quadruplex that recognises a nuclear
protein binding to the NHPPE duplex (10,11). In the present
work we report that the purine strand of NHPPE, located in the
proximal promoter sequence of KRAS, is also able to form a
G-quadruplex, suggesting that this unusual DNA structure
may be involved in transcription. We have characterized the
G-quadruplexes formed in the mouse and human promoters
through electrophoretic mobility shift assay (EMSA), circular
dichroism (CD), chemical probing with DMS/piperidine and
polymerase stop assays. Transfection experiments showed
that the stabilization of the KRAS G-quadruplex with the
cationic porphyrin TMPyP4 results in a strong inhibition
of KRAS transcription. Furthermore, DNA–protein com-
petition assays showed that the mouse and human KRAS
G-quadruplexes recognize a nuclear protein that binds to
duplex NHPPE. The sequestration of this protein by an
oligonucleotide mimicking the KRAS G-quadruplex, induced
a transcription inhibition to 40% of control. Our data suggest
a transcription mechanism that involves the formation of a
G-quadruplex within the KRAS promoter and shed light on
new molecular strategies to suppress the expression of KRAS
in tumour cells.
MATERIALS AND METHODS
DNA samples
The oligonucleotides illustrated in Table 1 were obtained
from Sigma-Proligo (Paris, France). The oligonucleotides
were puriﬁed by electrophoresis using a denaturing 20%
polyacrylamide gel (acrylamide:bisacrylamide, 19/1) in
TBE, 7 M urea, 55 C. The bands were excised from the
gel and eluted in water. The DNA solutions were ﬁltered
(Ultrafree-DA, Millipore) and precipitated. The concentration
of each DNA was determined from the absorbance at 260 nm
in milli Q water, using as extinction coefﬁcients 7500, 8500,
15 000 and 12 500 M
 1cm
 1 for C, T, A and G, respectively.
Plasmid pKRS-413 was a gift of D. L. George (University of
Pennsylvania).
Circular dichroism
CD spectra were obtained using a JASCO J-600 spectro-
polarimeter equipped with a thermostatted cell holder. The
DNAs used in the CD experiments were at a concentration
of 3 mM, in 50 mM Tris, pH 7.2 and 100 mM KCl. Spectra
were recorded in 0.5 cm quartz cuvette. A thermometer inser-
ted in the cuvette holder allowed a precise measurement of
the sample temperature. The spectra were calculated with
J-700 Standard Analysis software (Japan Spectroscopic Co.,
Ltd) and are reported as ellipticity (mdeg) versus wavelength
(nm). Each spectrum was recorded three times, smoothed and
subtracted to the baseline.
Native gel electrophoresis
Oligonucleotides (5 nM) end-labelled with [g-
32P]ATP
(Amersham, Pharmacia-Biotech, Milan) and polynucleotide
kinase were incubated for 3 h in the buffer as speciﬁed in
the ﬁgure legends. After incubation, the samples were loaded
on a 20% polyacrylamide (acrylamide: bisacrylamide, 19/1)
non-denaturing TBE gel and run for 2.5 h at 20 W with
temperature control at 25 C. The gels were ﬁxed in 10%
methanol, 10% acetic acid, dried and exposed to a Hyperﬁlm
MP (Amersham) at  80 C for few hours.
Preparation of nuclear extracts
Nuclear extracts were obtained as described by Dignam (25).
Brieﬂy,10·10cmplatesofconﬂuentPanc-1orNIH3T3cells
were collected and resuspended in hypotonic buffer. Swollen
cells were homogenizedwithaDounceandthe nuclei, pelleted
by centrifugation, were resuspended in low-salt buffer (20 mM
HEPES,pH7.9,25%glycerol,1.5mMMgCl2,0.02MKCl,0.2
mMEDTA,0.2mMphenylmethylsulfonylﬂuorideand0.5mM
Table 1. Oligonucleotides used in this study
50-GGGAGGGAGGGAAGGAGGGAGGGAGGGA 28Rm
50-GGGAGCGAGCGAAGGAGGGAGCGAGCGA 28Rmut
50-AGGGCGGTGTGGGAAGAGGGAAGAGGGGGAGG 32Rh
50-AGCGCGGTGTGCGAAGAGCGAAGAGCGGGAGG 32Rmut
50-TCCCTCCCTCCCTCCTTCCCTCCCTCCC 28Ym
50-CCTCCCCCTCTTCCCTCTTCCCACACCGCCCT 32Yh
50-UGGGGU Q1
50-GUUUUUGGGGCUUUUC Q2
50-TGGGGAGGGTGGGGAGGGTGGGGAAGG CMYC
Nucleic Acids Research, 2006, Vol. 34, No. 9 2537DTT).Releaseofnuclearproteinswasobtainedbytheaddition
of a high-salt buffer (as low-salt buffer but with 1.2 M KCl).
Protein concentration was measured according to the Lowry
method.
DMS footprinting and photocleavage experiments
Puriﬁed oligonucleotides 32Rh, 32Rmut, 28Rm and 28Rmut
(25 nM), end-labelled with [g-
32P]ATP (Amersham) and poly-
nucleotide kinase (New England Biolabs, MA), were incub-
ated overnight at 37 C, in 50 mM sodium cacodylate, pH 8,
1 mM EDTA, 50 or 100 mM KCl, 1 mg sonicated salmon
sperm DNA and 50 or 100 nM TMPyP4 as speciﬁed in ﬁgure
legends. Dimethylsulphate (DMS) dissolved in ethanol
(DMS:ethanol, 4/1, vol/vol) was added to the DNA solution
(1 ml to a total volume of 70 ml) and left to react for 5 min at
room temperature. For photocleavage experiments, the DNA
solutions containing 100 nM TMPyP4 were incubated in coco-
dylate buffer containing 100 mM KCl, and treated for 30 min
with a white light from a Solaris 2 (J615) projector (150 W) at
a ﬂuence rate of 64 mW/cm
2. Both DMS and Photocleavage
reactions were stopped by the addition of 1:4 vol of Stop
solution (1.5 M sodium acetate, pH 7, 1 M b-mercaptoethanol
and 1 mg/ml tRNA). DNA was precipitated with 4 vol of eth-
anol and resuspended in piperidine 1 M. After cleavage at
90 C for 30 min, reactions were stopped with chilling in
ice followed by precipitation with 0.3 M sodium acetate,
pH 5.2 and 3 vol of ethanol. The DNA samples were resus-
pended in 90% formamide and 50 mM EDTA, denatured at
90 C and run for 2 h on a denaturing 20% polyacrylamide gel,
prepared in TBE and 8 M urea, pre-equilibrated at 55 Ci na
Sequi-Gen GT Nucleic Acids Electrophoresis Apparatus
(Bio-Rad, CA), which was equipped with a thermocouple
that allows a precise temperature control. After running, the
gel was ﬁxed in a solutioncontaining 10% acetic acid and 10%
methanol, dried at 80 C and exposed to Hyperﬁlm MP
(Amersham) for autoradiography.
Polymerase stop assay
Plasmid pKRS-413 or KRAS single-stranded DNA templates
were subjected to a denaturation/renaturation cycle by
NaOH/HCl treatment. The treated DNAs (15 nM) were
mixed with the primer for DNA polymerase (7.5 nM, see
Figure 3), 100 mM KCl, 100 nM TMPyP4 and Klenow buffer
(New England Biolabs). After 24 h of incubation at 45 C,
the primer extention reactions were carried out in 30 min,
by adding 10 mM DTT, 100 mM dATP, dGTP, dTTP,
1 mM[ a-
32P]dCTP (7.4 Bq) and 3.75 U DNA Polymerase I
(large Klenow fragment) (New England BioLabs). The
reactions were stopped by adding an equal volume of stop
buffer (95% formamide, 10 mM EDTA, 10 mM NaOH,
0.1% xylene cyanol and 0.1% bromophenol blue). The pro-
ducts were separated on a 15% polyacrylamide sequencing
gel prepared in TBE, 8 M urea. The gel was dried and exposed
to autoradiography.
EMSA
Protein–DNA interactions were analysed by mobility shift
assays. End-labelled NHPPE duplexes (5 nM) were incubated
in 20 mM Tris–HCl, pH 8, 30 mM KCl, 1.5 nM MgCl2,1n M
DTT, 8% glycerol, 1% Phosphatase Inhibitor Cocktail I
(Sigma), 5 mM NaF, 1 mM Na3VO4, 25 nM poly(dIdC)
and 0.25 ng/ml nuclear extract, for 2 h at 37 C.
Southwestern blotting
An aliquot of 25 mg of nuclear protein extract were loaded
in each lane and separated in 8% PAGE–SDS gel and elec-
troblotted in 25 mM Tris, 192 mM Glycine, 20% methanol
and 0.1% SDS on a nitrocellulose transfer membrane. Dena-
turation was performed with 6 M guanidine–HCl for 30 min at
4 C, followed by renaturation with increasing dilutions with
HEPES-binding buffer (25 mM HEPES, pH 7.9, 4 mM KCl
and 3 mM MgCl2), 1:1, 1:2 and 1:4, each wash was carried
out at 4 C for 15 min. The blotted membrane was treated for
1 h with 5% non-fat milk in HEPES-binding buffer. Hybrid-
ization with radiolabelled DNA was carried out in 0.5%
non-fat dried milk, 1% NP40, 1 mg/ml poly(dIdC) in HEPES-
binding buffer, 1000 c.p.m./ml of radiolabelled probe, which
was preincubated in 50mM Tris–HCl, pH 7.4, 100 mM KCl
for 2 h at 37 C.
Cell cultures and transient transfections
Human transformed kidney 293 cells were cultured in
DMEM, containing 100 U/ml penicillin, 100 mg/ml strepto-
mycin, 200 mM L-glutamine and 10% foetal bovine serum
(Celbio, Milan, Italy). Cells were maintained in logarithmic
phase of growth. For transfection experiments, 6 · 10
5 cells
were seeded in a 35 mm culture dish and treated for 24 h
with TMPyP4 at different concentrations (3–15 mM). Each
plate was co-transfected with 2 mg of pKRS-413 and 50 ng
of pTK b-gal with calcium phosphate method. After 48 h,
ELISA assays were performed with CAT and b-gal ELISA
kits (Roche Diagnostics, Milan, Italy) as manufacturer’s
instructions. Samples were read at 405 nm with reference
ﬁlter at 490 nm with an Ultra Microplate Reader (Bio-Tek
Instruments, INC) with a kinetic reading for 40 min. Oligo-
nucleotides were transfected with Lipofectamine 2000
(Invitrogen) following manufacturer protocol 8 h before
plasmid transfection.
RESULTS
The purine strands of human and mouse polypurine-
polypyrimidine’s form G-quadruplex structures
The promoter of the KRAS gene contains a nuclease
hypersensitive polypurine–polypyrimidine element upstream
from the major transcription initiation site (13,14). This
sequence is located between nt  318/ 290 in mouse (Acces-
sion no. M16708),  327/ 296 in human (Accession no.
L00044), positions relative to the exon 0/intron 1 boundary.
Previous studies have shown that NHPPE is bound by nuclear
proteins and plays an essential role in transcription (14). The
NHPPE sequences are highly conserved in mouse and human
and characterized by a high C+G content (72% mouse, 67%
human) (Figure 1). Here, we asked whether the G-rich strands
of the NHPPEs adopt a non-B-DNA structure. Since G-rich
oligonucleotides can form quadruplex structures in KCl (26),
we analysed by CD the purine strands of the mouse and human
NHPPEs, namely 28Rm and 32Rh, and the corresponding
2538 Nucleic Acids Research, 2006, Vol. 34, No. 94-base mutant sequences, 28Rmut and 32Rmut, in 50 mM
Tris–HCl, pH 7.4 and 100 mM KCl. Figure 2A shows that
both 32Rh and 28Rm exhibit a CD spectrum characterized by
a strong and positive ellipticity at 260 nm and a weaker and
negative ellipticity at 240 nm. This spectrum is similar tothose
reported for oligonucleotides that are known to assume a par-
allel quadruplex structure, d(TGGGGT) (27,28) and d(GGA)4
(29). Interestingly, the CD spectra of the 4-base mutants
28Rmut and 32Rmut, in which the central guanine in four
runs of guanines (Table 1) has been replaced with cytosine,
appear dramatically different and not consistent with a quad-
ruplex structure. Another evidence that the KRAS G-rich
sequences form a G-quadruplex structure was obtained by
UV thermal difference spectra (TDS), as they provide a dis-
tinctive spectroscopic signature for G-quadruplex formation
(30,31). We have, measured the TDS spectra of 32Rh, 28Rm
and, for comparison, of the CMYC sequence (Table 1), that is
known to form a parallel quadruplex (32,33). The spectra
obtained (Supplementary Figures S1 and S2) show the typical
features of quadruplex DNA, with negative minima at 262
and 295 nm, positive maxima at 255 and 270, a shoulder at
245 nm (30,31). To determine the stability of the putative
parallel G-quadruplexes formed by 28Rm and 32Rh, we meas-
ured the CD spectra as a function of temperature and plotted
the ellipticity at 260 nm versus temperature. We obtained
two melting curves showing that the human and mouse
G-quadruplexes denatured in a cooperative way with Tm’s
of 64 and 73 C, respectively (data not shown). We then
wondered whether the parallel quadruplexes formed by the
two KRAS promoter sequences are intra- or intermolecular.
To answer this question, we analysed the electrophoretic
mobilities of 28Rm, 32Rh, 28Rmut and 32Rmut, under
native conditions (Figure 2B). The wild-type sequences
(5 nM), incubated either in NaCl or KCl, migrated in a
20% polyacrylamide gel much faster than the corresponding
duplexes. The mobility appeared only slightly slower than
the complementary pyrimidine strands or 4-base mutants,
which migrate as single-stranded species. This suggests that
both 28Rm and 32Rh adopt an intramolecular quadruplex
structure. In fact, increasing 200-fold the oligonucleotide
concentration from 5 nM to 1 mM, the mobility of the wild-
type sequences does not change [lane 5 (mouse); lane
9 (human)]. In principle, both 28Rm and 32Rh could form
G–G hairpins that associate into bimolecular quadruplexes.
However, these quadruplexes should have a mobility not
much different from that of the duplex; for instance TAG3T-
TAG3T, whose crystal shows that it forms a parallel bimolecu-
lar quadruplex (34), migrates in much the same way as the
duplex does (35). Finally, the observations that (i) the CD
spectra of 28Rm and 32Rh do not change following a DNA
dilution from 2 mM to 200 nM (data not shown), (ii) 28Rm
and 32Rh after denaturing give rapidly the typical CD signa-
ture and electrophoretic mobility (lanes 6 and 7 mouse; lanes 5
and 6 human), argue strongly in favour of an intramolecular
folding.
KRAS G-quadruplex arrests DNA polymerase
It has been shown that G-quadruplex structures are able
to block primer extension by DNA polymerase in a K
+-
dependent manner (36,37). We therefore designed four
DNA templates—two containing the mouse and human wild-
type G-rich sequences, two containing the 4-base mutant
sequences—and analysed their capacity to form an intra-
molecular G-quadruplex by a DNA polymerase arrest
assay. Figure 3 shows the results of primer extension experi-
ments performed with the mouse templates at 37 C, in the
presence of NaCl, KCl or KCl+TMPyP4 (tetra-(N-methyl-4-
pyridil porphyrin), a cationic porphyrin that stabilizes quad-
ruplex DNA (38). In order to determine the exact point
in which DNA polymerase was arrested, we sequenced the
template by the Sanger (dideoxy) method (lanes 1–4). A
potassium-dependent arrest of DNA polymerase at the aden-
ine preceding the ﬁrst run of guanines at the 30 side of the
G-rich sequence can be seen in lanes 6 and 7. This premature
chain termination product appeared stronger in the presence
Ex f Ex 1 Ex 2 Ex 3 Ex 4A Ex 4B
5’ 3’
+1
5’GCCGGCGCTCGCTGCCTCCCCCTCTTCCCTCTTCCCACACCGCCCTCAGCCGCTCCC
3’CGGCCGCGAGCGACGGAGGGGGAGAAGGGAGAAGGGTGTGGCGGGAGTCGGCGAGGG
5’CAGCGCTGCAGCCGCTCCCTCCCTCCCTCCTTCCCTCCCTCCCGCGCGCGCGGCCGAGG
3’GTCGCGACGTCGGCGAGGGAGGGAGGGAGGAAGGGAGGGAGGGCGCGCGCGCCGGCTCC 
human
mouse
-327 -296
-318 -290
5’-GGGCGGTGTGGGAA_GAGGGAAG_AGGGGGAG-3’ human
||| || | ||||| |||||| | |||| | 
5’-GGGAGG_GAGGGAAGGAGGGAGGGAGGGAG-3’ mouse
A
B
-326 -327
-318 -290
Figure 1. (A) Sequences of the NHPPEs contained in the human and mouse KRAS genes. Positions relative to exon 0/intron 1 boundary are shown. (B) Human and
mouse NHPPEs show a high sequence homology.
Nucleic Acids Research, 2006, Vol. 34, No. 9 2539of the stabilizing ligand TMPyP4. In addition to the primary
pausing site at the beginning of the G-rich motif, a secondary
pausing site is observed at the adenine preceding the second
run of guanines. This suggests the formation of an alternative
G-quadruplex within the mouse G-rich motif, starting from
the second 30 G-run. Note that in the presence of NaCl, DNA
polymerase was not arrested and produced a full length
transcript (lane 5). It is noteworthy that when 4 guanines
are replaced with cytosines, the polymerase was not arrested,
indicating that the 4-base mutant sequence did not form
a G-quadruplex, in accord with PAGE and CD (lanes
8–10). Next, we wondered whether the KRAS G-quadruplex
can be extruded from a double-stranded template containing
NHPPE. We performed primer extension experiments using
as template plasmid pKRS-413, which contains the mouse
KRAS promoter. We designed a primer complementary to a
sequence located downstream from the G-rich motif,
which was used for both DNA sequencing and primer
extension reactions (Figure 4). It can be seen that DNA
polymerase is arrested at the adenine preceding the ﬁrst
30 run of guanines, in perfect accord with the results obtained
with the single-stranded template. The arrest of polymerase
Figure 2. (A) CD spectra of the G-rich strands of the mouse (28Rm) and human (32Rh) NHPPEs and corresponding 4-base mutant sequences (28Rmut, 32Rmut).
Spectra have been obtained in 50 mM Tris, pH 7.2, 100 mM KCl, oligonucleotide concentration 3 mM. (B) Native electrophoretic mobilities of the NHPPE
duplexes, 28Rm, 32Rh, pyrimidine strands 28Ym and 32Yh, 28Rmut and 32Rmut under various experimental conditions. The oligonucleotides were
radiolabelled, incubated for 5 h in the appropriate buffer and run at 25 C in a 20% polyacrylamide gel in TBE. Samples in lanes 6 and 7 (left panel) and
5 and 6 (right panel) were denatured with NaOH and renatured with HCl.
2540 Nucleic Acids Research, 2006, Vol. 34, No. 9is potassium-dependent and stronger in the presence of
TMPyP4. In this case too, a secondary and weaker pausing
site is observed at the adenine preceding the second 30 G-run.
The polymerase stop assay was also performed with the
human single- and double-stranded templates and obtained
results similar to those observed for the parental mouse
templates (data not shown).
Determination of KRAS G-quadruplex structures
by DMS footprinting
To determine the nature of the G-quadruplexes formed by
the KRAS G-rich sequences, we probed the accessibility of
guanine N7 to DMS. While in duplex and single-stranded
DNA guanine N7 is available for methylation with DMS, in
quadruplex DNA, being involved in a Hoogsteen hydrogen
bond, N7 does not react with DMS. Figure 5 (left panel)
shows the results of a methylation assay performed on the
mouse 28Rm sequence in the denatured state (lanes 1–3),
after incubation in KCl (lane 4) or KCl+TMPyP4 (lane 5).
It can be seen that in the presence of KCl and TMPyP4,
most guanines are protected from methylation and thus
involved in G-tetrads, except G14 and G15 and, to a lesser
extent G17–G19. Taking into account the CD, PAGE and
primer extension experiments, we propose for this promoter
sequence an intramolecular parallel G-quadruplex that con-
sists of three G-tetrads, two one-base and one nine-base
external loops (structure Q[1/1/9], left). Such a propeller
type quadruplex conformation has been found for the telomere
d[AGGG(TTAGGG)3] in the crystalline state (34). Since pri-
mer extension experiments showed a secondary polymerase
pause at the adenine preceding the second 30 G-run, an altern-
ative quadruplex with two one-base and a 5-base external
loops, called Q[1/1/5], can be formed. Of the two quadruplex
loop isomers, Q[1/1/9] should have a higher stability,
according to polymerase stop assays. As the topology of
the loops cannot be predicted from DMS footprinting data,
we cannot rule out that the 9-base loop of Q[1/1/9] has a
diagonal topology as depicted in Q[1/1/9], right. Interestingly,
when a guanine in the G-runs involved in the tetrads is
substituted with cytosine, the resulting 4-base mutant
sequence exhibits a dramatically different DMS-induced
cleavage pattern, where all the guanines are modiﬁed and
cleaved by DMS/piperidine. This suggests that 28Rmut
does not adopt a quadruplex structure, in perfect accord
with CD, PAGE and primer extension experiments.
Figure 3. Polymerasestop assayshowingprimerelongationbythe Klenow fragment. The single-strandedtemplatescontainingeither 28Rmor 28Rmutare shown.
TheseDNAsubstrateshavebeenincubatedovernightinbufferscontainingNaCl,KClorKClandTMPyP4.Aprimerelongationreactionwasperformedfor30min
at 37 C. Elongation products were separated in a 15% polyacrylamide, 8 M urea, denaturing gel. Sequencing reactions by the Sanger dideoxy method, using the
same primer of the polymerase stop assay, were carried out. Klenow fragment elongation pauses in correspondence of the adenine preceding the first and second
runs of guanines at the 30 end of NHPPE, (positions are indicated by lines).
Nucleic Acids Research, 2006, Vol. 34, No. 9 2541Figure 4. Polymerase stop assay performed with a double-stranded template (plasmid pKRS-413). In this experiment pKRS-413, containing the mouse KRAS
promoter, has been incubated in 100 mM NaCl, 100 mM KCl or 100 mM KCl and 100 nM TMPyP4 at 45 C for 48 h. A primer elongation reaction was performed,
using a primer located downstream from the G-rich strand. Reactions were performed as described in Figure 3. The adenines in the G-rich sequence are numbered.
Figure 5. (Top) Sequence of the mouse G-rich motif 28Rm subjected to DMS footprinting. The four guanines that are substituted with cytosines in 28Rmut are
indicated (Bottom) DMS footprintings of the G-rich strand of NHPPE (28Rm) and 4-base mutant 28Rmut. DMS-induced cleavage of denatured 28Rm (lanes 1–3,
F¼formamide,D¼heating);28Rmafterincubationin100mMKCl(lane4)or100mMKClplus100nMTMPyP4(lane5);28RmutinF(lane6)and100mMKCl
plus 100nM TMPyP4 (lane 7). The guanines cleaved by the DMS/piperidine treatment are labelled in the right side of the sequencing gel. (Bottom right)
G-quadruplex structures proposed for 28Rm, based on DMS footprinting, CD, electrophoretic mobility and polymerase stop assays.
2542 Nucleic Acids Research, 2006, Vol. 34, No. 9Figure 6 shows the DMS footprinting for the human G-rich
sequence. In this sequence the guanines are distributed less
regularly than in the mouse sequence and three pyrimidines
disrupt the polypurine motif. However, when the two
sequences are aligned one against the other, their sequence
homology appears evident. In the presence of KCl (lanes 3 and
5) or KCl+TMPyP4 (lanes 4 and 6), a precise cleavage pattern
is obtained, with G9, G16, G18, G19, G20 and G23 showing a
high reactivity with DMS. This cleavage proﬁle shares com-
mon features with the proﬁle obtained with the mouse
sequence and supports the formation of a parallel
G-quadruplex stabilized by three G-tetrads and three external
loops (or two external and one diagonal loops), as the
G-quadruplex proposed for the mouse sequence. Note that
G29, but not the expected G28, is methylated by DMS: this
is probably due to the fact that TMPyP4 interacts with the
adenine bridging G29 and G31 rather than with G28 in the
miniloop. Again, the 4-base mutant sequence did not show any
footprint. To futher support the quadruplex structure proposed
for the human KRAS sequence we compared the Tm and CD
spectrum of 32Rh with those relative to a number of mutant
sequences. Interestingly, we did not observe changes in CD
shape and Tm when G18, G19, G20 or G9, G16, G23, were
replaced with thymidines. Conversely, when guanines
involved in a G-tetrad such as G12, G26 or G29 were
substituted with thymidines, dramatic changes in both the
CD and Tm were observed (data not shown).
Interaction between TMPyP4 with KRAS quadruplexes
Previous studies have demonstrated that the cationic
porphyrin TMPyP4 stabilizes quadruplex DNA (37–40).
We ﬁrst examined the interaction between TMPyP4 and the
mouse KRAS G-quadruplex by CD experiments. Figure 7A
shows the CD spectra of 3 mM 28Rm incubated in KCl or KCl
with three equivalents of TMPyP4. Although TMPyP4 is
achiral, a negative ellipticity appeared in the region of the
porphyrin Soret band ( 430 nm) as a result of the binding
of the ligand to the G-quadruplex. To determine the stabilizing
effect of TMPyP4 on the mouse quadruplex, we measured
the CD spectrum as a function of temperature, ﬁnding that
the Tm increased from 75 to >95 C (at 95 C the quadruplex
was not yet denatured). To gain insight into the interaction
between the cationic porphyrin and the mouse KRAS
G-quadruplex, we performed photocleavage experiments.
TMPyP4 catalyses the oxidation of DNA upon exposure to
light, resulting in DNA strand breakage in proximity of
the binding sites (38). The photocleavage of 28Rm and its
correspondent 4-base mutant sequence 28Rmut is shown in
Figure 6. (Top)SequenceofthehumanG-richmotif32RhsubjectedtoDMSfootprinting.Theguaninesthataresubstitutedwithcytosinesin32Rmutareindicated.
The parental 28Rm mouse sequence is also shown for comparison. Arrows indicate the cleavage sites (Bottom) DMS footprinting of the G-rich strand of the
human NHPPE (32Rh) and of the corresponding 4-base mutant 32Rmut. DMS-induced cleavage of the denatured 32Rm (lanes 1-2); 32Rh after incubation in
50 mM KCl (lane 3) or 50 mM KCl plus 50 nM TMPyP4 (lane 4); 32Rh in 100 mM KCl (lane 5) or 100 mM KCl plus 100 nM TMPyP4 (lane 6); 32Rmut in
formamide (lane 7), in 100 mM KCl (lane 8), in 100 mM KCl plus 100 nM TMPyP4 (lane 9). The guanines cleaved by the DMS/piperidine treatment are labelled
in the right side of the sequencing gel.
Nucleic Acids Research, 2006, Vol. 34, No. 9 2543Figure 7B. The two oligonucleotides show a distinct pho-
tocleavage pattern. Considering that TMPyP4 stabilizes the
quadruplex isomer with a 9-base loop, the DNA photodamage
occurs to the guanines of the external G-tetrads (G5, G9,
G25 and G27, indicated with red arrows) and the guanines
in the nine-base loop (G17, G18, G19, blue arrows). As G26,
although located in the internal G-tetrad, is cleaved
may be due to the fact that a fraction of 28Rm adopts the
Q[1/1/5] conformation, in which the ﬁrst 30 run of guanines is
excluded to the structure and is free to interact electrostat-
ically with TMPyP4. In conclusion, the data support the
notion that TMPyP4 binds to the mouse KRAS quadruplex
by end-stacking to the external G-tetrads and electrostatically
to the bases of the larger loop. These modes of binding are
in keeping with previous results obtained with telomeric
DNA (39) and with the CMYC quadruplex (17).
Figure 7. (A) CD spectra of the mouse G-rich sequence 28Rm in the presence of 100 mM KCl with and without TMPyP4. The ellipticity arising from the
28Rm-porphyrininteractionisshownintheinset.DNAconcentrationis3mM,TMPyP4increasedfrom3to18mM.Cuvettepathlength0.5cm.(B)Photocleavageof
theG-quadruplex formedby themouse28Rmsequence.DMS-induced cleavage of28Rmin thedenaturedstate (lane1),undera quadruplexconformation(lane2);
photocleavage of 28Rm in the quadruplex conformation (lane 3); DMS-induced cleavage of 28Rmut (lane 4), Photocleavage of 28Rmut (lane 5). Right structure
shows with arrows the guanines that are photocleaved.
2544 Nucleic Acids Research, 2006, Vol. 34, No. 9Quadruplex-stabilizing TMPyP4 strongly inhibits the
activity of the of KRAS promoter
The critical role played on transcription by the KRAS NHPPE
sequence motif has been demonstrated elsewhere (13,14).
Considering that NHPPE extrudes a G-quadruplex structure,
that is strongly stabilized by TMPyP4, we wished to evaluate
if this unusual DNA conformation does affect transcription.
It has been shown that TMPyP4 inhibits telomerase (41),
helicase-mediated unwinding of G-quadruplex structures
(42) and downregulates the expression of CMYC, whose pro-
moter also forms a G-quadruplex (43). In order to investigate
the effect of the cationic porphyrin on the activity of the
KRAS promoter, we co-transfected 293 cells with plasmid
pKRS-413, bearing the mouse KRAS promoter upstream
from the reporter CAT gene, plasmid pTK b-gal as a control
and increasing quantities of TMPyP4 (up to 20 mM). We
measured the expression of CAT relatively to that of b-gal
by ELISA assays, 48 h after transfection (Figure 8). We found
that at all the concentrations used, TMPyP4 reduced the
expression of CAT to 20% of the control, indicating that
the stabilization of the G-quadruplex has a strong repression
effect on transcription. This experiment suggests that the
quadruplex structure formed locally in the mouse KRAS pro-
moter at NHPPE behaves as a transcription repressor.
KRAS G-quadruplex recognises nuclear proteins
The NHPPE of KRAS is the target of nuclear proteins (14).
Little is known about these proteins except that they bind to
a promoter region that plays an essential role for transcrip-
tion. We performed EMSA with NIH 3T3 nuclear
extracts and the mouse
32P-labelled NHPPE duplex as a
probe. Figure 9A shows that three protein–DNA complexes
(M1–M3) are formed. These binding activities are sequence-
speciﬁc, as the experiments have been carried out in the pres-
ence of a large excess of polyd(I–C). When increasing
amounts of cold G-rich oligonucleotide 28Rm and 32Rh,
mimicking the mouse and human KRAS G-quadruplexes,
are added to the reaction mixture, they effectively competed
with the probe for protein binding. An oligonucleotide con-
centration 100-fold in excess over probe (radiolabelled
NHPPE duplex, 5 nM), is sufﬁcient to abrogate the interac-
tion responsible for the formation of complexes M1 and M2
(lanes 4 and 7), whereas the 4-base mutant oligonucleotide
28Rmut, at identical concentrations, had no effect (lanes
8–10). This indicates that the proteins in M1 and M2 are
recognized not only by the NHPPE duplex but also by the
G-quadruplexes formed by the G-rich strands of mouse and
human NHPPEs. The interaction between these proteins
and the KRAS quadruplexes is highly stereospeciﬁc, as
UGGGGU, forming a parallel quadruplex without loops
(called Q1) (44), does not compete with the duplex probe
(lane 14). EMSA experiments were also performed with
nuclear extracts from human Panc-1 cells (Figure 9B). In
this case we observed two DNA–protein complexes (H1
and H2) of which H1 is competed by the KRAS quadruplexes.
Here too, no competition is observed with the 4-base
mutant 28Rmut (lanes 6–8), Q1 and Q2, a G-quadruplex
with lateral loops formed by GUUUUUGGGGCUUUUC
(45) (lanes 11 and 12). Interestingly, the quadruplex formed
by the G-rich sequence present in the CMYC promoter shows
some competition with the duplex probe (lanes 13 and 14).
When we used the human NHPPE duplex as probe, we prac-
tically obtained the same results (data not shown). To further
characterize the binding between the mouse KRAS quadruplex
and the nuclear proteins, we performed a Southwestern ana-
lysis (Figure 9C). Nuclear extracts from mouse NIH 3T3 (M)
and human Panc-1 (H) cells were run in SDS–PAGE and
assayed with
32P-labelled 28Rm in the quadruplex conforma-
tion and
32P-labelled 28Rmut. Three binding activities are
observed with the mouse extract (at  32, 75 and 120 kDa),
whereas only two bands (32 and 75 kDa) are obtained with
the human extract. In accord with EMSA competition assays,
the 4-base mutant oligonucleotides did not show any binding
activity. To ﬁnd out if the bands observed in the Southwestern
blot are the subunits of a larger protein, we performed
UV-cross linking experiments under native conditions, but
unfortunately were not able to obtain reproducible results.
Finally, we addressed the question if the proteins that bind
to both the quadruplex and duplex conformations of mouse
NHPPE are essential for KRAS transcription. We reasoned
that an oligonucleotide mimicking the mouse KRAS
G-quadruplex should behave as an aptamer and cause a tran-
scription repression if the proteins that it binds to are essen-
tial for transcription. As proof of principle we transfected
293 cells with plasmid pKRS-413, containing CAT driven
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Figure 8. Chloramphenicol acetyl transferase expression assay to determine
the effect of TMPyP4 on the activity of KRAS promoter. Plasmid pKRS-413,
containing CAT driven by the mouse KRAS promoter, has been transfected
in 293 cells in the presence of increasing amounts of TMPyP4. As a control
for transfection efficiency and aspecific transcription impairment plasmid
pTK-bgal was cotrasfected with pKRS-413. The expression of CAT, with
respecttothatofb-gal,wasdeterminedbyanELISAassay,48haftertransfec-
tion. The residual CAT expression, (CAT/b-gal) · 100, is reported in the
histograms. The values are the average of three independent experiments in
duplicate. Error bar are ±SE. These experiments showed that stabilization
of G-quadruplex formed within NHPPE following cell treatment with
TMPyP4, decreased the expression of a reporter gene driven by the KRAS
promoter.
Nucleic Acids Research, 2006, Vol. 34, No. 9 2545by the mouse KRAS promoter, pTK b-gal and 1 mM
oligonucleotides 28Rm, 32Rh, 28Rmut and 32Rmut. The
results obtained are reported in Figure 10A which shows
that the KRAS transcription is reduced up to 40% of the
control in the presence of the quadruplex-forming oligonuc-
leotides. This is observed with both mouse and human
G-quadruplexes, indicating that the protein(s) binding to
the KRAS G-quadruplex is(are) essential elements for
transcription.
DISCUSSION
In this work we have demonstrated that the G-rich strand of
NHPPE, located within the proximal promoter region of
KRAS, is able to form a G-quadruplex structure that seems
to be involved in the mechanism of transcription regulation.
As the NHPPEs present in the human and mouse KRAS genes
share a high sequence homology (Figure 1), this structural
polymorphism is observed in both gene promoters. In order
to gain insight into the nature of these quadruplexes, we per-
formed spectroscopic and enzymatic experiments. CD (strong
ellipticity at 260 nm) and UV TDS (maximum at 273 nm)
showed spectral features indicative of the formation of a
parallel G-quadruplex structure (27,46). To discover whether
the KRAS quadruplexes are intra- or intermolecular, we ana-
lysed the mobility of the G-rich sequences in a native
polyacrylamide gel. As they migrated much faster than the
corresponding NHPPE duplexes and slightly slower than
the 4-base mutants, we concluded that they assume an
intramolecular folded quadruplex. The KRAS G-quadruplexes
were sufﬁciently stable [Tm ¼ 64 C (human) and 73 C
(mouse) in 100 mM KCl] to act as a barrier for DNA poly-
merase. The arrest of DNA synthesis was found to be K
+-
dependent and stronger in the presence of the cationic
porphyrin TMPyP4, which is known to stabilize quadruplex
DNA (38,39). The polymerase stop assays were performed
with both single- and double-stranded templates and showed
that the main arrest of DNA polymerase occurred at the
base preceding the ﬁrst run of guanines at the 30 side of the
G-rich sequence. However, a secondary enzymatic pause was
observed at the beginning of the second G-run, in keeping
with the formation of two quadruplex structures within
the mouse G-rich strand. An in-depth investigation on the
structure of the KRAS G-quadruplexes was obtained by DMS-
footprinting experiments. The cleavage patterns obtained
with the two KRAS G-rich sequences are consistent with
the formation of a parallel G-quadruplex structure character-
ized by three G-tetrads and three loops. As DMS-footprinting
data do not give information about the topology of the
loops, the three loops may be either all external (propeller
conformation), as found in the telomere d[AGGG(T-
TAGGG)3] repeat in the crystalline state (34), or two external
and one diagonal, as depicted in the structures of Figures 5
and 6. Moreover, as the mouse G-rich sequence comprises six
runs of guanines, two quadruplexes are formed, as suggested
Figure 9. DNA–protein competitionexperiments. (A) EMSAshowingthat
32P-labelledmouseNHPPEduplex (5nM)binds to threenuclearproteins froma mouse
NIH 3T3 cell extract (M1–M3) (lane 1). The competitors are: quadruplex 28Rm (lanes 2–4, 10-/50-/100-fold over the labelled duplex probe); quadruplex 32Rh
(lanes 5–7, 10-/50-/100-fold), 4-base mutant 28Rmut (lanes 8–10, 10-/50-/100-fold), target duplex (10-/50-/100-fold) (lanes 11–13); quadruplex Q1 (for sequences
see Table 1) (lane 14, 100-fold excess over probe) (lane 14). The autoradiography was analysed with a Gel Doc 2000 Imager System (Bio-Rad) and the percent OD
inbandsM1andM2respecttototalODinthelanewascalculated.Setto100thevalueobtainedinlane1(control),thevaluesofM1+M2inlanes1–14are100,92,63,
29, 73, 46, 24, 88, 81, 99, 1, 0, 0 and 82, respectively. These values provide a quantitative estimate of the competition capacity of the tested oligonucleotides;
(B) EMSA showing the
32P-labelled mouse NHPPE duplex (5 nM) binds to two nuclear proteins from human Panc-1 cells (H1 and H2) (lane 1). The competitors
are quadruplex 28Rm (lanes 2–5, 10-/20-/50-/100-fold over the probe); quadruplex 32Rh (lanes 9–10, 50-/100-fold); 4-base mutants 28Rmut (lanes 6–8, 10-/50-/
100-fold);quadruplexesQ1andQ2(forsequencesseeTable1)(lanes11and12,100-foldexcessoverprobe);quadruplexCMYC(sequenceinTable1)(lanes13,14,
50-/100-fold); Percent OD in H1 respect to total OD, measured in the lanes 1–14 are 100, 94, 77, 60, 41, 79, 77, 77, 46, 27, 83, 87, 68 and 69; (C) Southwestern
blots showing that 28Rm, but not the 4-base mutant 28Rmut, binds to nuclear proteins of 32, 75 and 115 kDa. The letters H and M on the top panelsindicate human
and mouse nuclear extracts, respectively. The mobilities of marker proteins are shown on the left.
2546 Nucleic Acids Research, 2006, Vol. 34, No. 9by the double arrest observed in the DNA polymerase stop
assay. In nice accord with CD and polymerase stop assays,
the 4-base mutants did not give a DMS footprinting. The
cationic porphyrin TMPyP4 was found to stabilize the
G-quadruplexes by  20 C. According to photocleavage
experiments, the porphyrin should stack to the external
G-tetrads of the mouse quadruplex and also interacts electro-
statically with the bases of the larger loop. To uncover the
biological function of the KRAS G-quadruplex, we transfected
293 cells with increasing amounts of TMPyP4 and vector
pKRS-413, containing CAT driven by the mouse KRAS pro-
moter. We found that the porphyrin promoted a strong
suppression of CAT to  20% of control, suggesting that
the G-quadruplex acts as a transcription repressor. A similar
result has been observed for CMYC, whose promoter also
contains a polypurine–polypyrimidine motif forming a
G-quadruplex (17,18). Although in these transfection experi-
ments TMPyP4 has not been site-directed against genomic
KRAS, the formation of a G-quadruplex in a critical region
of KRAS raises the intriguing possibility that this unorthodox
structure is somehow involved in transcription regulation.
This hypothesis is supported by the results obtained with
EMSA experiments. The mouse NHPPE duplex shows three
binding activities when incubated with nuclear extracts
obtained from mouse NIH 3T3 cells, namely M1, M2 and
M3. The single-stranded G-rich sequences of the mouse and
human KRAS genes competed with the duplex probe for the
binding to proteins in M1 and M2, but not in M3. The com-
petition is observed with the quadruplex-forming wild-type
sequences but not with the 4-base mutant sequences. Interest-
ingly, when the interaction between the mouse NHPPE
duplex and nuclear proteins was competed by oligonucleo-
tides forming G-quadruplexes with conformations different
from that proposed for KRAS (i.e. quadruplexes without
loops or with two lateral loops) no competition activity was
observed. The parallel quadruplex formed by the G-rich
sequence present in the CMYC promoter (47) was able to
compete partially with the duplex probe. These ﬁndings
suggest that the interaction between proteins M1/M2 and the
G-rich strand of KRAS is stereospeciﬁc and mediated by the
particular quadruplex structure assumed by this sequence
motif. In a previous study Michelotti et al. (48) have reported
a zinc-dependent binding activity by the guanine-rich
element of the CMYC promoter. This purine-rich strand
binding protein was identiﬁed as being CNBP: a cellular nuc-
leic acid binding protein implicated in the regulation of
sterol responsive genes. One could wonder if one of proteins
(M1 or M2; H1) that recognize the KRAS quadruplex is
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Figure 10. (A) CAT assay to determine the effect of 28Rmand 32Rh on KRAS transcription. Cells 293 were co-transfected withplasmid pKRS-413, pTK-bgal and
1mMquadruplex-formingoligonucleotide(28Rm,32Rh)or4-basemutant(28Rmut,32Rmut).TheexpressionofCATwithrespecttothatofb-gal,wasdetermined
by an ELISA assay, 48 h after transfection. The residual CAT expression, (CAT/b-gal) · 100, is reported in the histograms. The values are the average of three
independent experiments in duplicate. Error bars are ±SE. (B) Model for regulation of transcription in the KRAS gene.
Nucleic Acids Research, 2006, Vol. 34, No. 9 2547protein CNBP. This is not the case, as CNBP in
a SDS–polyacrylamide gel migrates with only one band of
20 kDa, whereas the KRAS quadruplexes show in the
SDS-polyacrylamide gel two binding activities: one at 32
kDa, the other at 75 kDa. Moreover, we observed that
the interaction between H1 and the KRAS quadruplex is not
abrogated by EDTA, i.e. it is not Zn
2+-dependent in the
same way as is the interaction between the CMYC sequence
and CNBP (data not shown).
Proteins binding sequence-speciﬁcally both the double-
stranded and single-stranded polypyrimidine motifs have
been reported as being hnRNP K (49,50) and NDPK-B (51).
The former recognizes a distinct sequence segment, namely
CTTCC, which is present in the human (two copies) and
mouse (one copy) KRAS NHPPEs. How can these nuclear
factors binding to the KRAS NHPPE duplex be correlated
with the G-quadruplex conformation adopted by NHPPE? In
Figure 10B we propose a scheme according to which KRAS
NHPPE should exist in equilibrium between double-stranded
and G-quadruplex conformations. When this structural equi-
librium shifts towards the quadruplex conformation, the tran-
scription should be repressed. This is suggested by the
transfection experiments with TMPyP4 and by the results
obtained with the CMYC promoter (17). Thus, it is possible
that the quadruplex conformation behaves as negative regu-
lator for KRAS. The unpaired polypyrimidine strand should
interact with the single-stranded binding protein hnRNP K
(49,50). To activate transcription, NHPPE should assume
its canonical double-stranded conformation, but this is
possible if the polypurine strand loses its unusual structure.
As the duplex-to-quadruplex transformation is probably a
slow process, it could be facilitated by a protein. It is likely
that one of the proteins recognising both the duplex and quad-
ruplexformsofNHPPEisinvolvedintheduplex-to-quadruplex
interconversion.Thisprovidesarationalfortheﬁndingthat293
cells transfected with a G-rich oligonucleotide mimicking the
KRAS quadruplexreducestheactivityoftheKRAS promoter to
40% of the control (4-base mutant sequence). In the
light of these results, oligonucleotides mimicking the
KRAS quadruplexes may have a potential anticancer activity,
as they interfere with the expression of KRAS. This is
supported by the data presented in this paper and by previous
data obtained with a stable transfectant cell line generating
constitutively a quadruplex-forming oligoribonucleotide that
strongly impairs cell proliferation (11). Another attractive
target for small ligands is the KRAS NHPPE quadruplex. The
selection from a chemical library of molecules that speciﬁ-
cally bind to the KRAS G-quadruplex could be an interesting
approach for the development of powerful anticancer drugs
against refractory pancreatic adenocarcinomas cells.
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